We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

CVS Health Corp (CVS) Common Stock USD0.01

Sell:$103.68 Buy:$103.69 Change: $1.69 (1.66%)
Market closed |  Prices as at close on 9 August 2022 | Switch to live prices |
Sell:$103.68
Buy:$103.69
Change: $1.69 (1.66%)
Market closed |  Prices as at close on 9 August 2022 | Switch to live prices |
Sell:$103.68
Buy:$103.69
Change: $1.69 (1.66%)
Market closed |  Prices as at close on 9 August 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CVS Health Corporation, together with its subsidiaries, is a health solutions company. The Company's segments include Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) solutions, including plan design offerings and administration, retail pharmacy network management services, mail order pharmacy, specialty pharmacy, clinical services, disease management services and medical spend management. Retail/LTC segment sells prescription drugs and a range of health and wellness products and general merchandise. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services. The Company's services include health & wellness services, health plans, pharmacy services and prescription drug coverage. The Company has approximately 9,000 retail locations, over 1,100 walk-in medical clinics, a pharmacy benefits manager.

Contact details

Address:
1 Cvs Dr
WOONSOCKET
02895-6146
United States
Telephone:
+1 (401) 7651500
Website:
https://cvshealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CVS
ISIN:
US1266501006
Market cap:
$134.25 billion
Shares in issue:
1.31 billion
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Karen Lynch
    President, Chief Executive Officer, Director
  • Shawn Guertin
    Chief Financial Officer, Executive Vice President
  • Laurie Havanec
    Chief People Officer, Executive Vice President
  • Tilak Mandadi
    Executive Vice President, Chief Data, Digital and Technology Officer
  • Thomas Moriarty
    Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
  • Troyen Brennan
    Executive Vice President, Chief Medical Officer
  • Daniel Finke
    Executive Vice President, President - Health Care Benefits
  • Joshua Flum
    Executive Vice President, Chief Strategy and Business Development Officer
  • Alan Lotvin
    Executive Vice President, President - CVS Caremark
  • Michelle Peluso
    Executive Vice President, Chief Customer Officer and Co-President of Retail

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.